Microbiome research in health and disease

CBmed provides translational microbiome research capabilities to investigate the role of the human gut microbiome in health, disease, and therapeutic response. Building on strong evidence that microbiome dysbiosis is both a driver and consequence of multiple acute and chronic diseases, CBmed bridges clinical observations with functional and mechanistic microbiome analyses.

CBmed offers a customizable microbiome research portfolio, translating clinical challenges into actionable research questions using well‑characterized clinical data and biosamples. Core capabilities include microbiome composition and functional analysis, identification of predictive and diagnostic biomarkers, bacterial strain isolation, and a patient‑derived microbiome modulation platform enabling functional testing of microbiome‑targeted interventions.

CBmed also brings specialized expertise in gut barrier biology, supported by validated gut permeability models and long‑standing clinical experience with gut permeability markers. Additional platforms support evaluation of probiotic and microbiome‑modulating strains for effects on gut barrier integrity, pathogen inhibition, and immune modulation, informing development of clinically relevant interventions.